These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16252213)

  • 1. [Lipoprotein(a) in coronary heart disease: clinical significance and therapeutic options].
    Leischik R; Dworrak B; Gülker H
    Dtsch Med Wochenschr; 2005 Nov; 130(44):2518-23. PubMed ID: 16252213
    [No Abstract]   [Full Text] [Related]  

  • 2. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management.
    Keller C
    Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High Lp (a) concentrations].
    Murase T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):96-9. PubMed ID: 9645017
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic variants in Lp(a) lipoprotein and coronary disease.
    Jaeger BR; Labarrere CA
    N Engl J Med; 2010 Mar; 362(12):1146-7; author reply 1147-8. PubMed ID: 20344827
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein(a).
    Enas EA; Dhawan J; Petkar S
    Indian Heart J; 1997; 49(1):25-34. PubMed ID: 9130422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipoprotein(a): epidemiology and therapeutic approaches].
    Kassner U; Thomas HP; Steinhagen-Thiessen E
    Dtsch Med Wochenschr; 2000 Nov; 125(44):1337-43. PubMed ID: 11109417
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum lipoprotein(a) levels in ischaemic heart disease.
    Singh RB
    J Assoc Physicians India; 1999 Aug; 47(8):846-7. PubMed ID: 10778647
    [No Abstract]   [Full Text] [Related]  

  • 8. Alcohol use, vascular disease, and lipid-lowering drugs.
    Kolovou GD; Salpea KD; Anagnostopoulou KK; Mikhailidis DP
    J Pharmacol Exp Ther; 2006 Jul; 318(1):1-7. PubMed ID: 16627749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein(a) and the cardiovascular risk].
    Pedro-Botet J; Sentí M
    Rev Esp Cardiol; 1994 Sep; 47(9):583-6. PubMed ID: 7973023
    [No Abstract]   [Full Text] [Related]  

  • 10. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
    Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M
    Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a): a unique risk factor for cardiovascular disease.
    Anuurad E; Boffa MB; Koschinsky ML; Berglund L
    Clin Lab Med; 2006 Dec; 26(4):751-72. PubMed ID: 17110238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of lipoprotein abnormalities in Indian patients.
    Chopra V; Wasir HS
    J Assoc Physicians India; 1998 Sep; 46(9):814-8. PubMed ID: 11229255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative treatment of coronary heart disease--current options].
    Desch S; Schuler G; Niebauer J
    MMW Fortschr Med; 2005 Feb; 147(8):45-7. PubMed ID: 18437860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
    Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
    Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to handle individual patients with or at risk for coronary heart disease. Coronary heart disease--still a threat.
    Schwandt P
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):205-11. PubMed ID: 11590997
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoprotein(a): importance for the fibrinolytic system and thromboembolic complications].
    Leischik R; Dworrak B
    Herz; 2006 Apr; 31(2):144-52. PubMed ID: 16738838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein (a) and coronary artery disease in Indians.
    Shahi SK; Ranga S
    Indian J Pathol Microbiol; 2000 Jan; 43(1):1-3. PubMed ID: 12583411
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoprotein[a]: a predictor of atherosclerotic disease.
    Harris ED
    Nutr Rev; 1997 Mar; 55(3):61-4. PubMed ID: 9170891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.